New York City Health Business Leaders (NYCHBL) Releases Second Annual Healthcare Venture Capital Report 2019

NYC Health Business Leaders > News  > New York City Health Business Leaders (NYCHBL) Releases Second Annual Healthcare Venture Capital Report 2019

New York City Health Business Leaders (NYCHBL) Releases Second Annual Healthcare Venture Capital Report 2019

With $1.85B Invested Across 83 Healthcare Companies, NYC Poised for Continued Growth


New York, NY (February 7, 2019) – New York City Health Business Leaders (NYCHBL) today released the second annual New York City Healthcare Venture Capital Report 2019, an in-depth analysis of the companies, investors and trends driving healthcare investment in New York. In addition to breaking down the numbers by total financings, sector and round, the report includes a ranking of the top 25 funded health companies, top investors to know and six trends to watch in 2019.

For the first time, the report also features insights and expertise from 15 of NYC’s top investors, entrepreneurs and advisors, including Zachariah Reitano, co-founder and CEO, Ro; Carolyn Magill, CEO, Aetion; Ellie Wheeler, partner, Greycroft; Drew Schiff, Managing Partner, Aisling Capital; and Wendy Goldstein and Yvan-Claude Pierre, Partners, Cooley.

“2018 was a remarkable year for healthcare investing in New York City with $1.85 billion invested across 83 healthcare companies,” said Bunny Ellerin, president, NYC Health Business Leaders. “The report shows how healthcare is vital to NYC’s economy in many ways – as an employer, innovator and care provider. We are excited to see what 2019 has in store for NYC.”

“From hospitals to medical schools to pharmaceutical companies, New York City is home to many of the most renowned healthcare institutions in the world,” said Zachariah Reitano, co-founder and CEO, Ro. “This has enabled Ro to benefit from the unparalleled wealth of knowledge of international thought leaders and to garner the enthusiastic support of medical experts in every field through each phase of our growth.”

Key highlights include:

  • Oscar ($540M); Ro ($88M) and Kallyope ($87M) are the top three businesses on the list of Top Funded NYC Health Companies in 2018.
  • Leading investors to know include Orbimed, Deerfield, FundRx, BoxGroup and Lerer Hippeau.
  • The six key trends for the year ahead relate to DTC, biotech, healthcare delivery, patient engagement, data analytics and the PBM industry.
  • On the topic of data analytics, the report predicts that as payment models shift from volume to value and clinical decisions become more complex, key stakeholders need advanced analytics to help them thrive.


“New York City has been an ideal location for us due to the volume of expertise within the region, across all sectors of healthcare, said Carolyn Magill, CEO, Aetion. “Not only is the talent pool diverse and full of people who are passionate about improving healthcare, we’re close to many of our current (and potential) partners—from biopharma to payers and providers, which enables us to build collaborative relationships between them.”

Cooley, a global law firm that has spent 40+ years representing many of the industry’s leading life sciences companies, helped gather the data for this report.



New York City Health Business Leaders is a professional community of 3,000 senior executives who are leading, innovating and driving healthcare forward. It was founded in 2009 by Bunny Ellerin and Dr. Yin Ho. Together they have created a healthcare ecosystem in New York that spans sectors, bringing together the best minds to discuss important issues and spur innovation. It is clear that by connecting the right people – leaders, professionals, entrepreneurs, investors – we can ignite the right conversations that advance all sides of health. For more information visit or follow us @nycbhl.


Media contact:
Jen Newman
tel: 917.587.9462